Xenco Medical unveils TrabeculeX Continuum
Medical technology company Xenco Medical has unveiled TrabeculeX Continuum, a convergent technology bridging digital health and biomaterials.
Comprising the TrabeculeX Bioactive Matrix and the TrabeculeX Recovery App, the TrabeculeX Continuum is a bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey. Empowering surgeons who have implanted Xenco Medical’s TrabeculeX Bioactive Matrix to enrol patients in the TrabeculeX Recovery App and engage in both Remote Therapeutic Monitoring and asynchronous video and text messaging, the TrabeculeX Continuum is an intersection of regenerative medicine and digital health.
Engineered to harness the hydroxycarbonate apatite-forming capabilities of bioglass in every TrabeculeX Bioactive Matrix, the regenerative biomaterial included in the TrabeculeX Continuum has been intricately designed by Xenco Medical to conduct three-dimensional bone-formation. Leveraging a complex surface topography, the TrabeculeX Bioactive Matrix’s architecture begins at the sub-micron scale and spans to the entire lattice itself. Bridging the journey from biomaterial implantation to full physical rehabilitation, the TrabeculeX Recovery App is designed to enable surgeons who’ve used a TrabeculeX Bioactive Matrix strip in their patient to prescribe and remotely monitor patient-specific physical rehabilitation plans with the ability to engage in asynchronous video and text messaging.
“As a surgical technology company devoted not only to our patients' intraoperative care but to their longitudinal recovery, we’ve committed ourselves to dissolving the barriers that currently exist in the siloed path from surgery to rehabilitation. With the TrabeculeX Continuum, we’re excited to introduce a connective technology that recognises the full arc of a patient’s journey rather than a single instance of care,” said Xenco medical founder and CEO Jason Haider.
Xenco Medical’s portfolio of disposable composite polymer surgery systems and biomimetic titanium foam spinal implants have been adopted by healthcare facilities nationwide. Xenco Medical was named one of the World’s Most Innovative Companies by Fast Company Magazine in its 2023 list.